ENTITY

Exact Sciences (EXAS US)

38
Analysis
Health CareUnited States
Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company's test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.
more
Refresh
bullishExact Sciences
09 Aug 2024 23:00

Exact Sciences Corporation: Expansion into Care Gap Programs & Other Major Drivers

Exact Sciences Corp. recently reported its second quarter 2024 earnings demonstrating strong performance and strategic advancements in its...

Logo
206 Views
Share
bullishExact Sciences
24 May 2024 14:00

Exact Sciences Corporation: Leveraging Health Systems and Electronic Ordering Channels To Catalyze Growth! - Major Drivers

Exact Sciences Corporation's first quarter 2024 earnings. The quarter demonstrated robust performance with first quarter revenue growing by 6% to...

Logo
295 Views
Share
bullishExact Sciences
29 Feb 2024 14:00

Exact Sciences Corporation: Launch Of MRD product OncoDetect & Other New Products! - Major Drivers

Exact Sciences Corporation showcased substantial growth and improved profitability throughout 2023. With a 24% increase in core revenue amounting...

Logo
174 Views
Share
bullishExact Sciences
01 Dec 2023 08:05

Exact Sciences Corporation: Cologuard Market Positioning & Long-Term Growth Strategy! - Major Drivers

Exact Sciences Corporation delivered a positive result and managed an all-around beat in the quarter. During the quarter, over 10,000 new...

Logo
127 Views
Share
bullishExact Sciences
27 Aug 2023 04:00

Exact Sciences Corporation: Cancer Research Through Collaborative Partnerships & Other Drivers

Exact Sciences Corporation exceeded Wall Street's revenue and earnings expectations. Revenue increased in the second quarter. Exact Sciences...

Logo
311 Views
Share
x